The DOI matches its Crossref record; 9 of the 10 references it cites were found in a registry or an index.
The global cost of nonoptimal blood pressure
Abstract
OBJECTIVE: Suboptimal blood pressure including established nonoptimal blood pressure has been shown to have significant economic consequences in developed countries. However, no exhaustive study has been done to evaluate its potential costs, globally. We, therefore, set out to estimate the global economic cost of nonoptimal blood pressure. METHODS: Estimates for healthcare costs attributed to suboptimal blood pressure for those over the age of 30 were made for all the World Bank regions. Annual and 10-year estimates using Markov models were made for the cost of treating nonoptimal blood pressure and its main sequelae: stroke and myocardial infarction. RESULTS: Suboptimal blood pressure cost US$370,000,000,000 globally in 2001. This represents about 10% of the world's overall healthcare expenditures. In the Eastern Europe and Central Asia region, high blood pressure consumed 25% of all health expenditures. Over a 10-year period, elevated blood pressure may cost nearly $1,000,000,000,000 globally in health spending, if current blood pressure levels persist. Indirect costs could be as high as $3,600,000,000,000 annually. CONCLUSION: Suboptimal blood pressure is responsible for a large and an increasing economic and health burden in developing countries. Although the majority of the current absolute expenditure occurs in the high-income countries, an ever-increasing proportion of the cost is going to be carried by developing countries.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“An estimated 10% of global health care spending is directly related to raised blood pressure and its complications such as isch -emic heart disease, heart failure, and stroke.”
From São Paulo call to action for the prevention and control of high blood pressure: 2020 (2019) · cites this paper as [16]
Citations
Cites
Global burden of blood-pressure-related disease, 2001
Lawes, C. M. M., Hoorn, S. V., & Rodgers, A. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60655-8 · Cited by 2,314
Law, M. R., Wald, N. J., Morris, J. K., & Jordan, R. E. (2003) · BMJ · doi:10.1136/bmj.326.7404.1427 · Cited by 1,232
Murray, C. J. L., Lauer, J. A., Hutubessy, R. C. W., Niessen, L. W., Tomijima, N., Rodgers, A., Lawes, C. M. M., & EVANS, D. B. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12655-4 · Cited by 602
van den Hoogen, P. C. W., Feskens, E. J. M., Nagelkerke, N. J. D., Menotti, A., Nissinen, A., & Kromhout, D. (2000) · New England Journal of Medicine · doi:10.1056/nejm200001063420101 · Cited by 552
Cardiovascular Disease in the Developing World and Its Cost-Effective Management
Gaziano, T. A. (2005) · Circulation · doi:10.1161/circulationaha.105.591792 · Cited by 441
Self-citationGaziano, T. A., Opie, L. H., & Weinstein, M. C. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69252-0 · Cited by 273
Self-citationMedical Care Expenditures for Hypertension, Its Complications, and Its Comorbidities
Hodgson, T. A., & Cai, L. (2001) · Medical Care · doi:10.1097/00005650-200106000-00008 · Cited by 172
Cost-Effectiveness Analysis of Hypertension Guidelines in South Africa
Gaziano, T. A., Steyn, K., Cohen, D. J., Weinstein, M. C., & Opie, L. H. (2005) · Circulation · doi:10.1161/circulationaha.105.535922 · Cited by 147
Self-citation
Research works printed but not linked: 1
- Lewington, 2002, Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies, Lancet, 360, 1903, 10.1016/S0140-6736(02)11911-8 · DOI · Paper page
Cited by
Sorted by citations
The global epidemiology of hypertension
Mills, K. T., Stefanescu, A. R., & He, J. (2020) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0244-2 · Cited by 4,777
Gheorghe, A., Griffiths, U. K., Murphy, A., Legido‐Quigley, H., Lamptey, P. R., & Perel, P. (2018) · BMC Public Health · doi:10.1186/s12889-018-5806-x · Cited by 571
Joffres, M., Falaschetti, E., Gillespie, C., Robitaille, C., Loustalot, F., Poulter, N., McAlister, F. A., Johansen, H., Baclic, O., & Campbell, N. (2013) · BMJ Open · doi:10.1136/bmjopen-2013-003423 · Cited by 464
Diabesity: an overview of a rising epidemic
Farag, Y. M. K., & Gaballa, M. (2010) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfq576 · Cited by 327
Hypertension awareness, treatment and control in Africa: a systematic review
Kayima, J., Wanyenze, R. K., Katamba, A., Leontsini, E., & Nuwaha, F. (2013) · BMC Cardiovascular Disorders · doi:10.1186/1471-2261-13-54 · Cited by 326
Metadata
- Authors
- Gaziano, T. A., Bitton, A., Anand, S., & Weinstein, M. C.
- Affiliations
- Brigham and Women's Hospital (US)
- Harvard University (US)
- Corresponding author
- Gaziano, Thomas A
- Venue
- Journal of Hypertension
- Published
- 2009-07
- Volume
- 27
- Issue
- 7
- Pages
- 1472-1477
- ISSN
- 0263-6352 (ISSN-L)
- OpenAlex
- W1986783669
- Cited by
- 303
- References
- 10
- Citations by year
- 2026: 12 · 2025: 17 · 2024: 15 · 2023: 19 · 2022: 26 · 2021: 20 · 2020: 20 · 2019: 13 · 2018: 17 · 2017: 14 · 2016: 26 · 2015: 22 · 2014: 14 · 2013: 13 · 2012: 18
- FWCI
- 11.55
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Hypertension (publishedVersion)
- PubMed (publishedVersion)
- Funders
- International Society of Hypertension
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Global Health Care Issues
- Keywords
- hypertension, economic burden of disease, health care costs, stroke, myocardial infarction, indirect costs, developing countries
- MeSH terms
- Developing Countries, Humans, Hypertension, Markov Chains, Global Health, Cost of Illness
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
